We are live on ! Find out more
ZIM

Zacks Investment Management Portfolio holdings

AUM $12.5B
1-Year Est. Return 29.36%
This Fund
S&P 500
This Quarter Est. Return
+18.29%
1 Year Est. Return
+29.36%
3 Year Est. Return
+98.03%
5 Year Est. Return
+139.15%
10 Year Est. Return
+465.5%
AUM
$4.55B
AUM Growth
+$471M
Cap. Flow
-$144M
Cap. Flow %
-3.17%
Top 10 Hldgs %
21.2%
Holding
610
New
118
Increased
118
Reduced
253
Closed
110

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$32.4M
2
CTVA icon
Corteva
CTVA
+$31.9M
3
PEG icon
Public Service Enterprise Group
PEG
+$26M
4
RTX icon
RTX Corp
RTX
+$12.1M
5
ABBV icon
AbbVie
ABBV
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Healthcare 15.06%
3 Financials 14.64%
4 Consumer Staples 10.68%
5 Consumer Discretionary 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAWW
476
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$209K ﹤0.01%
+4,866
New +$171K
DE icon
477
Deere & Co
DE
$164B
$203K ﹤0.01%
+1,294
New +$188K
RSX
478
DELISTED
VanEck Russia ETF
RSX
$202K ﹤0.01%
9,734
-1,725
-15% -$34K
VST icon
479
Vistra
VST
$48B
$194K ﹤0.01%
+10,413
New +$196K
YEXT icon
480
Yext
YEXT
$577M
$186K ﹤0.01%
+11,186
New +$157K
EPOL icon
481
iShares MSCI Poland ETF
EPOL
$817M
$181K ﹤0.01%
10,889
-1,135
-9% -$17.6K
HRB icon
482
H&R Block
HRB
$5.82B
$175K ﹤0.01%
+12,266
New +$194K
BCRX icon
483
BioCryst Pharmaceuticals
BCRX
$2.51B
$139K ﹤0.01%
+29,149
New +$116K
CNCE
484
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$134K ﹤0.01%
+13,431
New +$129K
FCEL icon
485
FuelCell Energy
FCEL
$1.59B
$132K ﹤0.01%
+1,950
New +$120K
CNR
486
DELISTED
Cornerstone Building Brands, Inc.
CNR
$122K ﹤0.01%
20,214
-45,955
-69% -$235K
DHT icon
487
DHT Holdings
DHT
$2.95B
$109K ﹤0.01%
21,319
+11,294
+113% +$72K
BGC icon
488
BGC Group
BGC
$4.86B
$107K ﹤0.01%
+39,215
New +$109K
PDLI
489
DELISTED
PDL BioPharma, Inc.
PDLI
$105K ﹤0.01%
35,915
+17,995
+100% +$56.9K
NAT icon
490
Nordic American Tanker
NAT
$1.33B
$81K ﹤0.01%
+20,054
New +$95K
F icon
491
Ford
F
$55.8B
$77K ﹤0.01%
12,672
-3,187,373
-100% -$17.7M
RUBY
492
DELISTED
Rubius Therapeutics, Inc
RUBY
$74K ﹤0.01%
+12,364
New +$73K
VRAY
493
DELISTED
ViewRay, Inc.
VRAY
$65K ﹤0.01%
+28,884
New +$61.6K
CBIO
494
Crescent Biopharma
CBIO
$644M
$64K ﹤0.01%
170
AXTI icon
495
AXT Inc
AXTI
$4.83B
$49K ﹤0.01%
+10,209
New +$48.1K
LYG icon
496
Lloyds Banking Group
LYG
$88.8B
$19K ﹤0.01%
12,837
DNR
497
DELISTED
Denbury Resources, Inc.
DNR
$12K ﹤0.01%
44,820
-716,149
-94% -$215K
CASH icon
498
Pathward Financial
CASH
$1.81B
$11K ﹤0.01%
+11,106
New +$195K
TMUSR
499
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
$11K ﹤0.01%
+66,433
New +$18.7K
XXII
500
22nd Century Group
XXII
$1.5M
0

Similar funds

Zacks Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Zacks Investment Management held 610 positions worth $4.55B, up 12% from $4.08B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Zacks Investment Management withdrew a net $144M in Q2 2020, closing 110 positions and reducing 253 holdings. Its most notable exit was Steel Dynamics, an estimated $15.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Zacks Investment Management opened a new position in ConocoPhillips worth $33.6M.

  • Zacks Investment Management's largest Q2 2020 buy was ConocoPhillips: 800,504 shares worth $33.6M.
  • Zacks Investment Management added most to AbbVie in Q2 2020, an estimated $10.4M increase.
  • Zacks Investment Management's biggest Q2 2020 reduction was Ameriprise Financial, cutting an estimated $42.7M.
  • Zacks Investment Management fully exited Steel Dynamics in Q2 2020, selling an estimated $15.5M.
  • Zacks Investment Management's ten largest holdings make up 21% of its $4.55B portfolio in Q2 2020.
  • Zacks Investment Management opened 118 new positions and closed 110 in Q2 2020.
  • Zacks Investment Management's portfolio value rose 12% quarter-over-quarter to $4.55B.

Based on Zacks Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.